Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RenovoRx (RNXT)
NASDAQ:RNXT
Holding RNXT?
Track your performance easily
RNXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $2.35
Previous Close$1.09
Volume13.35K
Average Volume (3M)34.32K
Market Cap
$26.16M
Enterprise Value$16.56M
Total Cash (Recent Filing)$9.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.27
Next Earnings
Nov 11, 2024EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding24,001,339
10 Day Avg. Volume31,906
30 Day Avg. Volume34,316
Standard Deviation0.49
R-Squared0.01
Alpha-0.00174
Financial Highlights & Ratios
Price to Book (P/B)3.76
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.11
Forecast
1Y Price Target
$6.13Price Target Upside462.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
RenovoRx News
PremiumPre-Earnings
Is RNXT a Buy, Before Earnings?
Ownership Overview
1.90% Insiders
1.02% Mutual Funds
1.77% Other Institutional Investors
95.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RNXT FAQ
What was RenovoRx’s price range in the past 12 months?
RenovoRx lowest stock price was $0.53 and its highest was $2.35 in the past 12 months.
What is RenovoRx’s market cap?
Currently, no data Available
When is RenovoRx’s upcoming earnings report date?
RenovoRx’s upcoming earnings report date is Nov 11, 2024 which is 10 days ago.
How were RenovoRx’s earnings last quarter?
RenovoRx released its earnings results on Aug 14, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.105 by $0.005.
Is RenovoRx overvalued?
According to Wall Street analysts RenovoRx’s price is currently Undervalued.
Does RenovoRx pay dividends?
RenovoRx does not currently pay dividends.
What is RenovoRx’s EPS estimate?
RenovoRx’s EPS estimate is -$0.11.
How many shares outstanding does RenovoRx have?
RenovoRx has 24,001,339 shares outstanding.
What happened to RenovoRx’s price movement after its last earnings report?
RenovoRx reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.105. Following the earnings report the stock price went up 1.754%.
Which hedge fund is a major shareholder of RenovoRx?
Currently, no hedge funds are holding shares in RNXT
---
RenovoRx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.13 (462.39% Upside)
$6.13 (462.39% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
46.70%
12-Months-Change
Fundamentals
Return on Equity
-258.95%
Trailing 12-Months
Asset Growth
185.05%
Trailing 12-Months
Company Description
RenovoRx
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
---
RNXT Stock 12 Month Forecast
Average Price Target
$6.13
▲(462.39% Upside)
Technical Analysis
Actinium Pharmaceuticals
―
Cardiff Oncology
―
TuHURA Biosciences
―
Aileron Therapeutics
―
Best Analysts Covering RNXT
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-37.85%
reiterated a buy rating 7 months ago
Copying Scott Henry's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -37.85% per trade.
---